Zetta Genomics

Zetta Genomics builds genomic data analysis platforms for precision medicine and healthcare.

Cambridge, UK—Founded 2017

£3.7MTotal raised

Zetta Genomics operates as a genomic data pioneer centred on tertiary genomic data analysis platforms to advance precision medicine. The company develops technologies designed to empower clinicians and researchers with efficient data management and scalable analytics.

Founders

Ignacio Medina

Founder and CEO

Investors

Seed9 February 2024
£1.8M
WV
We Venture
Nina CapitalFollow-on
AV
Apex Ventures
Cambridge EnterpriseFollow-on
Seed17 April 2023
£1.9M
Nina CapitalLead
APEX Ventures
Cambridge Enterprise

Funding history

Seed9 February 2024

£1.8M

Zetta Genomics secures £1.8m seed extension from We Venture Capital and existing backers to scale operations

The funding extension was backed by new investor We Venture Capital alongside returning backers Nina Capital, Apex Ventures, and Cambridge Enterprise to prepare the firm for Series A.

Seed17 April 2023

£1.9M

Zetta Genomics secures £1.9m in seed follow on funding led by Nina Capital

Nina Capital led the seed follow on round to support international growth and product scaling.